{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:18:49Z","timestamp":1778030329077,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MSD Ltd","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00520-018-4524-3","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T11:55:59Z","timestamp":1541246159000},"page":"1497-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability"],"prefix":"10.1007","volume":"27","author":[{"given":"Judith","family":"Lacey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna J.","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marthick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"key":"4524_CR1","unstructured":"Australian Cancer Incidence and Mortality (ACIM) (2017) Melanoma of the Skin for Australia (ICD10 C43). Available from: \n                    http:\/\/www.aihw.gov.au\/acim-books"},{"issue":"4","key":"4524_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","volume":"37","author":"KM Mahoney","year":"2015","unstructured":"Mahoney KM, Freeman GJ, McDermott DF (2015) The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma. Clin Ther 37(4):764\u2013782","journal-title":"Clin Ther"},{"issue":"26","key":"4524_CR3","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long G, Arance A, Grob J, Mortier L et al (2015) Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 372(26):2521\u20132532","journal-title":"N Engl J Med"},{"issue":"10105","key":"4524_CR4","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","volume":"390","author":"J Schachter","year":"2017","unstructured":"Schachter J, Ribas A, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank C, Petrella TM, Hamid O, Zhou H, Ebbinghaus S, Ibrahim N, Robert C (2017) Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Lancet 390(10105):1853\u20131862","journal-title":"Lancet"},{"key":"4524_CR5","unstructured":"Pharmaceutical Benefits Advisory Committee (2018) Schedule of pharmaceutical benefits. In: Health Do (ed) Commonwealth of Australia, Canberra, Australia"},{"key":"4524_CR6","doi-asserted-by":"publisher","first-page":"e180798","DOI":"10.1001\/jamaoncol.2018.0798","volume":"4","author":"JM O\u2019Connor","year":"2018","unstructured":"O\u2019Connor JM, Fessele KL, Steiner J, Seidl-Rathkopf K, Carson KR, Nussbaum NC, Yin ES, Adelson KB, Presley CJ, Chiang AC, Ross JS, Abernethy AP, Gross CP (2018) Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials. JAMA Oncol 4:e180798","journal-title":"JAMA Oncol"},{"issue":"1","key":"4524_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.17925\/EOH.2016.12.01.25","volume":"12","author":"R Eeden van","year":"2016","unstructured":"van Eeden R, Rapoport BL (2016) Supportive care of patients undergoing immunotherapy. Eur Oncol Haematol 12(1):25\u201327","journal-title":"Eur Oncol Haematol"},{"issue":"8","key":"4524_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00520-009-0615-5","volume":"17","author":"JD Harrison","year":"2009","unstructured":"Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ (2009) What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 17(8):1117\u20131128","journal-title":"Support Care Cancer"},{"issue":"8","key":"4524_CR9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/annonc\/mdx205","volume":"28","author":"HM Dhillon","year":"2017","unstructured":"Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, Lewis C, Hui R, Blinman P, Clarke SJ, Boyer MJ, Vardy JL (2017) Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol 28(8):1889\u20131897","journal-title":"Ann Oncol"},{"issue":"11","key":"4524_CR10","first-page":"CD006145","volume":"11","author":"F Cramp","year":"2012","unstructured":"Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11(11):CD006145","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"4524_CR11","first-page":"CD008465","volume":"8","author":"SI Mishra","year":"2012","unstructured":"Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 8(8):CD008465","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"4524_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733\u2013742","journal-title":"N Engl J Med"},{"issue":"2","key":"4524_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00520-011-1327-1","volume":"20","author":"M Carey","year":"2012","unstructured":"Carey M, Lambert S, Smits R, Paul C, Sanson-Fisher R, Clinton-McHarg T (2012) The unfulfilled promise: a systematic review of interventions to reduce the unmet supportive care needs of cancer patients. Support Care Cancer 20(2):207\u2013219","journal-title":"Support Care Cancer"},{"issue":"8","key":"4524_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw 13(8):1012\u20131039","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"4524_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40425-015-0078-9","volume":"3","author":"L Khoja","year":"2015","unstructured":"Khoja L, Butler MO, Kang SP, Ebbinghaus S, Joshua AM (2015) Pembrolizumab. J Immunother Cancer 3(1):36","journal-title":"J Immunother Cancer"},{"issue":"17","key":"4524_CR16","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","volume":"32","author":"JE Bower","year":"2014","unstructured":"Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 32(17):1840\u2013U127","journal-title":"J Clin Oncol"},{"issue":"5","key":"4524_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.mcna.2017.04.011","volume":"101","author":"G Lopez","year":"2017","unstructured":"Lopez G, Mao J, Cohen L (2017) Integrative oncology. Med Clin N Am 101(5):977\u2013985","journal-title":"Med Clin N Am"},{"key":"4524_CR18","doi-asserted-by":"crossref","unstructured":"Grant S, Marthick M, Lacey J (2018) Establishing an integrative oncology service in the Australian healthcare setting\u2014the Chris O\u2019Brien Lifehouse Hospital experience. Supportive Care in Cancer. (published online)","DOI":"10.1007\/s00520-018-4460-2"},{"issue":"3","key":"4524_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570\u2013579","journal-title":"J Clin Oncol"},{"issue":"3","key":"4524_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","volume":"53","author":"DB Hui","year":"2016","unstructured":"Hui DB, Eduardo (2016) The Edmonton symptom assessment system 25\u00a0years later: past, present, and future developments. J Pain Symptom Manag 53(3):630\u2013643","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"4524_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"4524_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1207\/s15327914nc5301_6","volume":"53","author":"JA Read","year":"2005","unstructured":"Read JA, Crockett N, Volker DH, MacLennan P, Choy STB, Beale P, Clarke SJ (2005) Nutritional assessment in Cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer 53(1):51\u201356","journal-title":"Nutr Cancer"},{"key":"4524_CR23","unstructured":"Institute NC (2010) Common terminology criteria for adverse events (CTCAE). In: Services UDoHaH (ed) NIH"},{"issue":"2","key":"4524_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"6","key":"4524_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/pon.1428","volume":"18","author":"M Janda","year":"2009","unstructured":"Janda M, DiSipio T, Hurst C, Cella D, Newman B (2009) The Queensland Cancer Risk Study: general population norms for the Functional Assessment of cancer Therapy-General (FACT-G). Psychooncology 18(6):606\u2013614","journal-title":"Psychooncology"},{"key":"4524_CR26","volume-title":"Calculating nom-based T-scores from your FACT-G data","author":"Office QoL","year":"2018","unstructured":"Office QoL (2018) Calculating nom-based T-scores from your FACT-G data. POCOG, University of Sydney, Sydney Available from: \n                    www.pocog.org.au\/pod\/factgscores.aspx"},{"key":"4524_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ctrv.2016.02.003","volume":"45","author":"TK Eigentler","year":"2016","unstructured":"Eigentler TK, Hassel JC, Berking C, Aberle J, Bachmann O, Gr\u00fcnwald V, K\u00e4hler KC, Loquai C, Reinmuth N, Steins M, Zimmer L, Sendl A, Gutzmer R (2016) Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy. Cancer Treat Rev 45:7\u201318","journal-title":"Cancer Treat Rev"},{"issue":"14","key":"4524_CR28","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. Journal of Clinical Oncology 32(14):1480","journal-title":"Journal of Clinical Oncology"},{"key":"4524_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejon.2017.06.002","volume":"29","author":"G Kotronoulas","year":"2017","unstructured":"Kotronoulas G, Papadopoulou C, MacNicol L, Simpson M, Maguire R (2017) Feasibility and acceptability of the use of patient-reported outcome measures (PROMs) in the delivery of nurse-led supportive care to people with colorectal cancer. Eur J Oncol Nurs 29:115\u2013124","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"4524_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00520-007-0283-2","volume":"15","author":"M Polley","year":"2007","unstructured":"Polley M, Seers J, Cooke HJ, Hoffman C, Paterson C (2007) How to summarise and report written qualitative data from patients: a method for use in cancer support care. Support Care Cancer 15(8):963\u2013971","journal-title":"Support Care Cancer"},{"issue":"9","key":"4524_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00432-018-2700-y","volume":"144","author":"E Ben-Arye","year":"2018","unstructured":"Ben-Arye E, Dahly H, Keshet Y, Dagash J, Samuels N (2018 Sep) Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care. J Cancer Res Clin Oncol 144(9):1825\u20131833","journal-title":"J Cancer Res Clin Oncol"},{"issue":"30_suppl","key":"4524_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1200\/jco.2014.32.30_suppl.64","volume":"32","author":"H Solomon","year":"2014","unstructured":"Solomon H, Brown C, Vennettilli A, Zarrin A, Dobriyal A, Chen L et al (2014) Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: evaluating patient acceptability. Journal of Clinical Oncology 32(30_suppl):64","journal-title":"Journal of Clinical Oncology"},{"key":"4524_CR33","doi-asserted-by":"crossref","unstructured":"Grimmett C, Haviland J, Winter J, Calman L, Din A, Richardson A, et al (2017) Colorectal cancer patient's self-efficacy for managing illness-related problems in the first 2 years after diagnosis, results from the ColoREctal Well-being (CREW) study. J Cancer Surviv","DOI":"10.1007\/s11764-017-0636-x"},{"issue":"4","key":"4524_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/bmjspcare-2012-000381","volume":"5","author":"E Lobb","year":"2015","unstructured":"Lobb E, Lacey J, Kearsley J, Liauw W, White L, Hosie A (2015) Living with advanced cancer and an uncertain disease trajectory: an emerging patient population in palliative care? BMJ Support Palliat Care 5(4):352\u2013357","journal-title":"BMJ Support Palliat Care"},{"issue":"5","key":"4524_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/pon.1921","volume":"21","author":"M Serfaty","year":"2012","unstructured":"Serfaty M, Wilkinson S, Freeman C, Mannix K, King M (2012) The ToT Study: helping with Touch or Talk (ToT): a pilot randomised controlled trial to examine the clinical effectiveness of aromatherapy massage versus cognitive behaviour therapy for emotional distress in patients in cancer\/palliative care. Psycho-Oncology 21(5):563\u2013569","journal-title":"Psycho-Oncology"},{"issue":"23","key":"4524_CR36","first-page":"13","volume":"3","author":"M Dieng","year":"2015","unstructured":"Dieng M, Kasparian NA, Morton RL, Mann GJ, Butow PN, Menzies S et al (2015) The Melanoma Care Study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychology 3(23):13","journal-title":"BMC Psychology"},{"key":"4524_CR37","doi-asserted-by":"crossref","unstructured":"Levy D, Dhillon HM, Lomax A, Marthick M, McNeil C, Kao S, Lacey J (2018) Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy. Support Care Cancer","DOI":"10.1007\/s00520-018-4443-3"},{"issue":"14","key":"4524_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebb\u00e9 C, Ascierto PA, Long GV, Cebon J, Sosman J, Postow MA, Callahan MK, Walker D, Rollin L, Bhore R, Hodi FS, Larkin J (2017) Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 377(14):1345\u20131356","journal-title":"N Engl J Med"},{"key":"4524_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejca.2017.05.031","volume":"82","author":"D Schadendorf","year":"2017","unstructured":"Schadendorf D, Larkin J, Wolchok J, Hodi FS, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao C, Wagstaff J, Callahan MK, Postow MA, Smylie M, Ferrucci PF, Dummer R, Hill A, Taylor F, Sabater J, Walker D, Kotapati S, Abernethy A, Long GV (2017) Health-related quality of life results from the phase III CheckMate 067 study. Eur J Cancer 82:80\u201391","journal-title":"Eur J Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4524-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4524-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T20:08:30Z","timestamp":1572725310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4524-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4524"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4524-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"6 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}